Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

IMPORTANCE: Level I evidence has failed to demonstrate an overall survival (OS) advantage for cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma (ccRCC) in the modern era, which is at odds with observational studies reporting a marked OS benefit associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakiryan, Nicholas H., Gore, L. Robert, Reich, Richard R., Dunn, Rodney L., Jiang, Da David, Gillis, Kyle A., Green, Elizabeth, Hajiran, Ali, Hugar, Lee, Zemp, Logan, Zhang, Jingsong, Jain, Rohit K., Chahoud, Jad, Spiess, Philippe E., Manley, Brandon J., Sexton, Wade J., Hollenbeck, Brent K., Gilbert, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112069/
https://www.ncbi.nlm.nih.gov/pubmed/35576003
http://dx.doi.org/10.1001/jamanetworkopen.2022.12347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112069/
https://www.ncbi.nlm.nih.gov/pubmed/35576003
http://dx.doi.org/10.1001/jamanetworkopen.2022.12347

Ejemplares similares